Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $20.0000 (0.86%) ($19.8400 - $20.0100) on Wed. Feb. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.96% (three month average) | RSI | 54 | Latest Price | $20.0000(0.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.1% a day on average for past five trading days. | Weekly Trend | HALO advances 1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(54%) IWO(54%) IWM(50%) IWC(49%) XBI(49%) | Factors Impacting HALO price | HALO will decline at least -0.98% in a week (0% probabilities). VIXM(-38%) VXX(-19%) UUP(-7%) TLT(-3%) SHY(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.98% (StdDev 1.96%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
5 Day Moving Average | $19.87(0.65%) | 10 Day Moving Average | $19.64(1.83%) | 20 Day Moving Average | $19.63(1.88%) | To recent high | -1.1% | To recent low | 19.3% | Market Cap | $2.733b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |